Prudential Financial’s Crescent Biopharma CBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding CBIO
OM
Prudential Financial's CBIO Position: Q3 2026 in Review
Prudential Financial opened a new position in Crescent Biopharma (CBIO) in Q3 2026: 21,032 shares worth $307K. The stake represents ﹤0.01% of the portfolio and ranks #2154 among its holdings.
104 funds tracked by Wall St. Rank hold CBIO as of Q3 2026.
- Prudential Financial held 21,032 shares of Crescent Biopharma worth $307K as of Q3 2026.
- Crescent Biopharma was a new Prudential Financial position in Q3 2026.
- Crescent Biopharma made up ﹤0.01% of Prudential Financial's portfolio in Q3 2026, its #2154 holding.
- 104 funds tracked by Wall St. Rank held Crescent Biopharma as of Q3 2026.
Based on Prudential Financial's 13F filing for Q3 2026, filed 16 Nov 2026.